Showing 261 - 265 of 265
  • 12 April, 2016 - 15:15
    ​EIT Health UK and Ireland CoLocation Centre (UKI CLC) Application for Headstart
    The European Institute of Innovation and Technology (EIT) is an independent body of the European Union set up to spur innovation and entrepreneurship across Europe to overcome some of its greatest challenges. 
    As part of its “Accelerator” activities, EIT Health provides funding for emerging companies and SMEs to develop new products and services for areas of interest to EIT Health and its members. The purpose of the funding is to accelerate market entry and create new economic activity and applications to support research will be rejected. Seven awards of up to 50K€ are available and funds must be spent by 31st December 2016.

    Proof of concept funding is suitable for individuals and organisations that have a well- developed prototype and are ready to launch a product. Applications will be accepted from organisations that are not yet incorporated as companies but we will expect that a company will be formed within six months of the funding

    Headstart funding is open to established companies that are already trading in the UK and Ireland but wish to explore new markets.

    Priority areas

    The UKI CLC is now seeking applications from companies and individuals based in the UK and Ireland in the following challenge areas defined by our industry partners as follows:
    1. P&G Challenge: Innovation in consumer products
    2. IBM & Pfizer Challenge: Novel Solutions for Improving Medication Adherence
    3. Pfizer Challenge: New Solutions to Facilitate Chronic Disease Management
    4. “Wild Card” Challenge
    Benefits: In addition to the 50K€ our industry partners will provide access to innovation facilities and networks as well as mentorship to successful applicants.

    More information can be found here

    Deadline: Proposals must be received by noon on Tuesday 31st May 2016. Applicants should provide a completed application form and a video pitch by email to Please note, word limits must be strictly adhered to; any sections that exceed the word count will be excluded.

    Evaluation: Proposals will be reviewed by a team of experts drawn from the UKI CLC and representatives of local VCs and confidentiality agreements will be in place. Successful proposals will be those that provide a compelling case for the use of the funding to accelerate the route to market.

    Key performance indicators (KPIs): Successful proposals will be expected to deliver one or more of the following KPIs:
    •   Business ideas incubated and progressed to market
    •   Start-ups or spin off companies created
    •   Products or services launched
    •   New markets accessed
    •   Jobs created. 
  • 23 March, 2016 - 12:49
    EU Third Health Programme Launches 2016 Call for Projects
    The EU's Third Health Programme Call for Projects is currently accepting applications for 2016.

    The Third Health Programme is the European Commission’s main instrument to implement the EU health strategy. It is implemented by means of annual work plans which set out priority areas and the criteria for funding actions under the programme. The total budget for the programme is €449.4 million.
    Public authorities and public sector bodies in EU Member States are eligible to apply, in particular research and health institutions, universities and higher education establishments. NGOs (non-governmental, non-profit-making, independent of industry, commercial and business or other conflicting interests) working in the public health area may be eligible for operational grants.

    The Third Health Programme aims to support and complement the work of EU Member States to achieve four objectives:
    • Promote health, prevent diseases and foster supportive environments for healthy lifestyles taking into account the 'health in all policies' principle.
    • Protect EU citizens from serious cross-border health threats.
    • Contribute to innovative, efficient and sustainable health systems.
    • Facilitate access to better and safer healthcare for EU citizens.
    The following topics are open under the 2016 Call for Proposals:
    • Migrants’ health: Best practices in care provision for vulnerable migrants and refugees - budget: €4.5 million.
      • Supporting activities in view of the development of community-based care models to improve health care access of vulnerable migrants and refugees.
    • Gathering knowledge and exchanging best practices on measures reducing underage drinking and heavy episodic drinking - budget: €1.2 million.
      • Supporting Member States’ efforts to reduce alcohol related harm and particularly contribute to the objectives of the Member States’ action plan on Youth Drinking and on Heavy Episodic Drinking.
    • Gathering knowledge and exchanging best practises to on measures to prevent illicit drug use in line with the minimum quality standards in drug demand reduction - budget: €600,000.
      • Preventing and delay the age of onset of illicit drug use, thus supporting the EU Action Plan on Drugs and the implementation of the minimum quality standard in drug demand reduction.
    • Support to Member States and stakeholders to address the chronic disease challenge - budget: €2.5 million.
      • Identifying and addressing key elements with a potential to reduce the burden of major chronic diseases and increase the sustainability of health systems.
    • Donor selection and protection - budget: €550,000.
      • Increasing the safety of donation and clinical application of tissues and cells and/or blood by optimising the procedures for donor selection and protection.
    The deadline for applications to the 2016 Call for Projects is 2 June 2016.

    Full details can be found on the website of the European Commission's Directorate for Public Health and Risk Assessment.

    Source: EC Directorate for Public Health and Risk Assessment, 09/03/2016
  • 21 March, 2016 - 14:53
    WMAHSN Meridian launch event a huge success
    More than 100 people from the NHS, academic and industry sectors packed out the Vox Conference Centre on 1 March for the launch of the Meridian health innovation exchange.

    It was standing room only as the audience gathered to hear a selection of speakers talk about the impact of healthcare innovation, including David Johnson, who spoke of the importance of innovation from a carer's perspective, and Dr Damian Williams, GP at Hall Green Health, Clinical Lead for Birmingham CrossCity CCG and Digital Clinical Champion with NHS England, who discussed the importance of a collaborative approach to innovation. After the WMAHSN team ran through the Innovation and Adoption Service, the benefits and features of Meridian and outcomes and deliverables, it was time for attendees to network and visit the three campaign stations to see how Meridian could be used to address the challenges of the AHSN's priorities and themes

    The slide deck from the event is now available, as well as a simple Getting Started guide to assist you in uploading your innovation submissions and campaigns. If you would like additional support or advice on using the site or your submissions, please don’t hesitate to contact Chris Dyke or Joanne Mewis at Medilink West Midlands - they would be more than happy to help. 

    Your feedback is very important to us and we would greatly appreciate if you could take the time to complete a short survey to give your views on the event.

  • 26 February, 2016 - 12:57
    Quantum Imaging Ltd chooses West Midlands as its New Home
    Quantum Imaging Ltd, an exciting medical device company looking to revolutionise the way the NHS diagnoses patients presenting at A&E with chest pain, has chosen Coventry for its new Head Quarters.

    The company opened its purpose-designed commercial and development facility in the heart of the city in February 2016. It is currently recruiting locally and hopes to bring a range of new roles to the area as the company grows.

    The new facility will be home to product development including the ground-breaking Quantum Vitalscan, a portable medical device that can scan a patient presenting with chest pain in less than 5 minutes, helping doctors to rule out acute cardiac conditions, such as a heart attack or severe heart disease. Vitalscan can be used in hospital A&E departments directly at a patient’s bedside and produces highly accurate 2D imaging maps of the patient’s heart.

    The new building will also support vital research undertaken in conjunction with the University of Leeds.

    Steve Parker, CEO of Quantum Imaging Ltd said: “We have chosen Coventry for its central location and excellent business opportunities. We are already working with local healthcare organisation, Medilink West Midlands, and believe Coventry to be the ideal place for our business to evolve.”

    Quantum Imaging is currently looking for experienced software and hardware engineers and experienced quality professionals to fill a range of new roles. In addition the company is looking to bring in specialist, experienced Healthcare professionals to help bring Quantum Vitalscan to market, potentially saving money, time and lives.

    Quantum Imaging originated out of the University of Leeds in 2014 to commercialise imaging technology developed in the university’s Quantum Information group and two completed clinical studies have provided strong evidence and the basis for further product development. The company’s first area of development is the rapid triage of patients presenting in the Emergency Department with chest pain.

    For Further Information please visit the Quantum Imaging website or contact:

    Steve Parker (CEO) (t): 07743 895261 or 01926 670560 (e):

    Leander Clarke, Speed Communications (t): 07985 238713 (e):
  • 22 January, 2016 - 16:43
    Promoting Life Sciences and Healthcare Technology Sector across the West Midlands Region
    Showcasing the quality and scope of Medilink members and the region’s health technology sector, the Medilink WM Winter 2015 Newsletter will keep you up to date with the latest developments in the West Midlands as well as connect you with fellow members and their news.

    The WM Newsletter brings together the region’s health technology community, including research institutes and NHS organisations encouraging innovation, networking and collaboration.

    In this edition find out more about:
    • How we can guide and support you as the WMAHSN industry gateway to help you UNLOCK YOUR POTENTIAL to do business with the NHS through the Innovation and Adoption service
    • The WMAHSN, including their aims and the launch of their new Digital Health incubator
    • Our NEW MEMBERS, as well as our NEW PRODUCTS for Alvolution
    • How Medilink will carry on championing our sector’s SKILLS need by maintaining the subsidised delegate rate you enjoyed through SIP with our exceptional rates and training programmes
    With links to international business opportunities, funding competitions and key information including an update on global medical device regulations as well as how we can help promote your innovations, the WM Winter Newsletter will keep you up to date with NEWS from our members, key sector UPDATES and EVENTS – all of which reflect the strength of the Life Sciences & Healthcare Technologies sector in the West Midlands.

    DOWNLOAD your copy now - click here.